Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-03-02 21:17:47 ET
Zymeworks Inc. (ZYME) Q4 2025 Earnings Call March 2, 2026 8:30 AM EST
Company Participants
Shrinal Inamdar - VP of Investor Relations
Kenneth Galbraith - Chairman of the Board, CEO, Acting CFO & President
Bijal Desai - Senior Vice President of Finance
Sabeen Mekan - SVP & Chief Medical Officer
Paul Moore - Chief Scientific Officer
Adam Schayowitz - Acting Chief Development Officer
Scott Platshon - Acting Chief Investment Officer
...
Read the full article on Seeking Alpha
For further details see:
Zymeworks Inc. (ZYME) Q4 2025 Earnings Call Transcript
Zymeworks Inc.
NASDAQ: ZYME
ZYME Trading
-4.5% G/L:
$22.72 Last:
289,903 Volume:
$23.42 Open:
ZYME Latest News
March 02, 2026 06:10:00 am
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
March 02, 2026 06:01:00 am
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
ZYME Stock Data
$1,697,666,774
73,882,368
0.51%
61
N/A
Biotechnology & Life Sciences
Healthcare
CA
Middletown
